South Pharmaceutical is a leading producer of paclitaxel and its intermediates in the Chinese pharmaceutical industry. It is the developer of the national standard "Technical Regulations for the Cultivation of Taxus mairei and Paclitaxel Raw Material Forests in the South," and one of the largest planting bases for Taxus mairei and production bases for paclitaxel and its intermediates in China. The company emphasizes technological innovation and the construction of its research and development team, holding 8 PCT international invention patents and 23 Chinese invention patents.
South Pharmaceutical has a strong sense of social responsibility, focusing on environmental protection and green development. It has a comprehensive environmental management and occupational health and safety management system (EHS system).
福建(jian)南(nan)方制藥股份有限公司(si)(證(zheng)券代碼:831207)成立于2001年(nian)9月(yue),致力于以紫(zi)杉(shan)醇原料藥為代表的(de)抗腫瘤藥物的(de)研(yan)發(fa)(fa)和生產(chan),是一家集藥物種植、研(yan)發(fa)(fa)、生產(chan)、銷售于一體的(de)GMP制藥企業。公司(si)旗下雪峰、瀚仙兩個廠區占地面積共(gong)13.1萬平方米,擁有4000畝(mu)優選南(nan)方紅(hong)豆杉(shan)種植基地。
南方(fang)制藥(yao)(yao)是中國(guo)(guo)制藥(yao)(yao)行業領先的紫杉(shan)烷類原料(liao)藥(yao)(yao)及中間體(ti)產品生(sheng)產企(qi)業,是國(guo)(guo)家標準《南方(fang)紅豆(dou)(dou)杉(shan)紫杉(shan)醇原料(liao)林豐產栽培技(ji)術(shu)規程》的制定(ding)者,是中國(guo)(guo)最大的紅豆(dou)(dou)杉(shan)種植基地和紫杉(shan)烷類產品生(sheng)產供(gong)應基地之一。公司重(zhong)視技(ji)術(shu)革(ge)新和研(yan)發(fa)隊(dui)伍的建設,現有8項PCT國(guo)(guo)際(ji)發(fa)明(ming)專利、23項中國(guo)(guo)發(fa)明(ming)專利。
南方制藥(yao)富有良好的社會責任感,致力于環(huan)境(jing)保護(hu)和(he)綠色發展,擁有完備的環(huan)境(jing)管理和(he)職業健康(kang)安(an)全(quan)管理體系(EHS體系)。
Fujian South Pharmaceutical Co., Ltd. (Stock Code: 831207) was established in September 2001. It is committed to the research and production of anti-tumor drugs, with paclitaxel as its representative, and is a GMP pharmaceutical enterprise integrating drug planting, research, production, and sales. The company's two factory areas, Xuefeng and Hanxian, cover a total area of 131,000 square meters and have a 4,000-acre high-quality southern yew planting base.
通(tong)過國家藥品GMP認證
Obtained National Drug GMP Certification
首次通過國家高技術(shu)企業資格認證(zheng)
First-time accreditation as a National High-Tech Enterprise
旗下南方(fang)制藥公(gong)司新三板上市(證券代碼:831207)
South Pharmaceutical Company, a subsidiary, listed on the New Third Board (Securities Code: 831207)
通過美國FDA現(xian)場審計(ji)
Passed on-site audit by the U.S. Food and Drug Administration (FDA)
榮(rong)獲(huo)高(gao)新技術企業(ye)(ye)、國(guo)家林業(ye)(ye)重點(dian)龍頭(tou)企業(ye)(ye)等稱號(hao)
Honored with titles such as High-Tech Enterprise and National Forestry Key Leading Enterprise
通過歐盟EDQM藥品質量(liang)認證
Passed the European Directorate for the Quality of Medicines & HealthCare (EDQM) certification for drug quality
榮獲國家專精特新(xin)“小巨人”企業稱號
2021: Awarded the title of "National Specialized and Innovative 'Small Giant' Enterprise"
與上海熙(xi)華藥業合作,投(tou)資「福建熙(xi)華醫藥產(chan)業園」
Cooperated with Shanghai Xihua Pharmaceutical Industry to invest in the 「Fujian Xihua Pharmaceutical Industrial Park」